Lisa Cox
Hospitalist · Maryville, MONPI 1366824039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,591 and has fallen 95.7% since, to $69 in 2022. Among hospitalist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $13.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$640
- Boehringer Ingelheim$542
- Lilly USA, LLC$510
- Novo Nordisk$400
- AstraZeneca$385
- AbbVie$345
- plus $946 from 12 others
What the payments were for
- Food & beverage$3,769100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 48 | $640 |
| Boehringer Ingelheim | 39 | $542 |
| Lilly USA, LLC | 38 | $510 |
| Novo Nordisk | 25 | $400 |
| AstraZeneca | 23 | $385 |
| AbbVie(2 entities) | 37 | $345 |
| Johnson & Johnson | 23 | $283 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $163 |
| Amgen | 9 | $159 |
| E.r. Squibb & Sons, L.L.C. | 6 | $82 |
| GSK | 5 | $78 |
| Jazz Pharmaceuticals Inc. | 4 | $65 |
| Radius Health, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$3,769 in reported general payments places this provider in the 95th percentile of 712 hospitalist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 13 | $356 |
| Donepezil Hcl | 13 | $319 |
| Cefdinir | 21 | $228 |
| Potassium Chloride | 19 | $208 |
| Doxycycline Hyclate | 27 | $196 |
| Prednisone | 48 | $127 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $120 |
| Amlodipine Besylate | 12 | $82 |
| Cephalexin | 21 | $76 |
| Oxycodone Hcl | 11 | $42 |
| Levofloxacin | 13 | $25 |
| Furosemide | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Maryville
- Mir ZulqarnainKansas City$161K
- Gian MusarraSaint Louis$25K
- Ghassan DaherSaint Louis$23K
- Marsha SchulteSaint Louis$23K
- Ijeoma NwelueSaint Louis$12K
- Karan MohanSt. Joseph$6K
- Aniesh BobbaColumbia$6K
- Arun MannemSaint Louis$6K
- Vasanthan KuppuswamySaint Louis$5K
- Yamuna KondapallySaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.